A high-content neuron imaging assay demonstrates inhibition of prion disease-associated neurotoxicity by an anti-prion protein antibody

Abstract There is an urgent need to develop disease-modifying therapies to treat neurodegenerative diseases which pose increasing challenges to global healthcare systems. Prion diseases, although rare, provide a paradigm to study neurodegenerative dementias as similar disease mechanisms involving pr...

Full description

Bibliographic Details
Main Authors: Madeleine Reilly, Iryna Benilova, Azadeh Khalili-Shirazi, Christian Schmidt, Parvin Ahmed, Daniel Yip, Parmjit S. Jat, John Collinge
Format: Article
Language:English
Published: Nature Portfolio 2022-06-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-13455-z
_version_ 1818207666561875968
author Madeleine Reilly
Iryna Benilova
Azadeh Khalili-Shirazi
Christian Schmidt
Parvin Ahmed
Daniel Yip
Parmjit S. Jat
John Collinge
author_facet Madeleine Reilly
Iryna Benilova
Azadeh Khalili-Shirazi
Christian Schmidt
Parvin Ahmed
Daniel Yip
Parmjit S. Jat
John Collinge
author_sort Madeleine Reilly
collection DOAJ
description Abstract There is an urgent need to develop disease-modifying therapies to treat neurodegenerative diseases which pose increasing challenges to global healthcare systems. Prion diseases, although rare, provide a paradigm to study neurodegenerative dementias as similar disease mechanisms involving propagation and spread of multichain assemblies of misfolded protein (“prion-like” mechanisms) are increasingly recognised in the commoner conditions such as Alzheimer’s disease. However, studies of prion disease pathogenesis in mouse models showed that prion propagation and neurotoxicity can be mechanistically uncoupled and in vitro assays confirmed that highly purified prions are indeed not directly neurotoxic. To aid development of prion disease therapeutics we have therefore developed a cell-based assay for the specific neurotoxicity seen in prion diseases rather than to simply assess inhibition of prion propagation. We applied this assay to examine an anti-prion protein mouse monoclonal antibody (ICSM18) known to potently cure prion-infected cells and to delay onset of prion disease in prion-infected mice. We demonstrate that whilst ICSM18 itself lacks inherent neurotoxicity in this assay, it potently blocks prion disease-associated neurotoxicity.
first_indexed 2024-12-12T04:32:33Z
format Article
id doaj.art-6c3d427e537748449f547bcad8e6d4f9
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-12-12T04:32:33Z
publishDate 2022-06-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-6c3d427e537748449f547bcad8e6d4f92022-12-22T00:38:02ZengNature PortfolioScientific Reports2045-23222022-06-0112111210.1038/s41598-022-13455-zA high-content neuron imaging assay demonstrates inhibition of prion disease-associated neurotoxicity by an anti-prion protein antibodyMadeleine Reilly0Iryna Benilova1Azadeh Khalili-Shirazi2Christian Schmidt3Parvin Ahmed4Daniel Yip5Parmjit S. Jat6John Collinge7MRC Prion Unit at UCL, UCL Institute of Prion Diseases, University College LondonMRC Prion Unit at UCL, UCL Institute of Prion Diseases, University College LondonMRC Prion Unit at UCL, UCL Institute of Prion Diseases, University College LondonMRC Prion Unit at UCL, UCL Institute of Prion Diseases, University College LondonMRC Prion Unit at UCL, UCL Institute of Prion Diseases, University College LondonMRC Prion Unit at UCL, UCL Institute of Prion Diseases, University College LondonMRC Prion Unit at UCL, UCL Institute of Prion Diseases, University College LondonMRC Prion Unit at UCL, UCL Institute of Prion Diseases, University College LondonAbstract There is an urgent need to develop disease-modifying therapies to treat neurodegenerative diseases which pose increasing challenges to global healthcare systems. Prion diseases, although rare, provide a paradigm to study neurodegenerative dementias as similar disease mechanisms involving propagation and spread of multichain assemblies of misfolded protein (“prion-like” mechanisms) are increasingly recognised in the commoner conditions such as Alzheimer’s disease. However, studies of prion disease pathogenesis in mouse models showed that prion propagation and neurotoxicity can be mechanistically uncoupled and in vitro assays confirmed that highly purified prions are indeed not directly neurotoxic. To aid development of prion disease therapeutics we have therefore developed a cell-based assay for the specific neurotoxicity seen in prion diseases rather than to simply assess inhibition of prion propagation. We applied this assay to examine an anti-prion protein mouse monoclonal antibody (ICSM18) known to potently cure prion-infected cells and to delay onset of prion disease in prion-infected mice. We demonstrate that whilst ICSM18 itself lacks inherent neurotoxicity in this assay, it potently blocks prion disease-associated neurotoxicity.https://doi.org/10.1038/s41598-022-13455-z
spellingShingle Madeleine Reilly
Iryna Benilova
Azadeh Khalili-Shirazi
Christian Schmidt
Parvin Ahmed
Daniel Yip
Parmjit S. Jat
John Collinge
A high-content neuron imaging assay demonstrates inhibition of prion disease-associated neurotoxicity by an anti-prion protein antibody
Scientific Reports
title A high-content neuron imaging assay demonstrates inhibition of prion disease-associated neurotoxicity by an anti-prion protein antibody
title_full A high-content neuron imaging assay demonstrates inhibition of prion disease-associated neurotoxicity by an anti-prion protein antibody
title_fullStr A high-content neuron imaging assay demonstrates inhibition of prion disease-associated neurotoxicity by an anti-prion protein antibody
title_full_unstemmed A high-content neuron imaging assay demonstrates inhibition of prion disease-associated neurotoxicity by an anti-prion protein antibody
title_short A high-content neuron imaging assay demonstrates inhibition of prion disease-associated neurotoxicity by an anti-prion protein antibody
title_sort high content neuron imaging assay demonstrates inhibition of prion disease associated neurotoxicity by an anti prion protein antibody
url https://doi.org/10.1038/s41598-022-13455-z
work_keys_str_mv AT madeleinereilly ahighcontentneuronimagingassaydemonstratesinhibitionofpriondiseaseassociatedneurotoxicitybyanantiprionproteinantibody
AT irynabenilova ahighcontentneuronimagingassaydemonstratesinhibitionofpriondiseaseassociatedneurotoxicitybyanantiprionproteinantibody
AT azadehkhalilishirazi ahighcontentneuronimagingassaydemonstratesinhibitionofpriondiseaseassociatedneurotoxicitybyanantiprionproteinantibody
AT christianschmidt ahighcontentneuronimagingassaydemonstratesinhibitionofpriondiseaseassociatedneurotoxicitybyanantiprionproteinantibody
AT parvinahmed ahighcontentneuronimagingassaydemonstratesinhibitionofpriondiseaseassociatedneurotoxicitybyanantiprionproteinantibody
AT danielyip ahighcontentneuronimagingassaydemonstratesinhibitionofpriondiseaseassociatedneurotoxicitybyanantiprionproteinantibody
AT parmjitsjat ahighcontentneuronimagingassaydemonstratesinhibitionofpriondiseaseassociatedneurotoxicitybyanantiprionproteinantibody
AT johncollinge ahighcontentneuronimagingassaydemonstratesinhibitionofpriondiseaseassociatedneurotoxicitybyanantiprionproteinantibody
AT madeleinereilly highcontentneuronimagingassaydemonstratesinhibitionofpriondiseaseassociatedneurotoxicitybyanantiprionproteinantibody
AT irynabenilova highcontentneuronimagingassaydemonstratesinhibitionofpriondiseaseassociatedneurotoxicitybyanantiprionproteinantibody
AT azadehkhalilishirazi highcontentneuronimagingassaydemonstratesinhibitionofpriondiseaseassociatedneurotoxicitybyanantiprionproteinantibody
AT christianschmidt highcontentneuronimagingassaydemonstratesinhibitionofpriondiseaseassociatedneurotoxicitybyanantiprionproteinantibody
AT parvinahmed highcontentneuronimagingassaydemonstratesinhibitionofpriondiseaseassociatedneurotoxicitybyanantiprionproteinantibody
AT danielyip highcontentneuronimagingassaydemonstratesinhibitionofpriondiseaseassociatedneurotoxicitybyanantiprionproteinantibody
AT parmjitsjat highcontentneuronimagingassaydemonstratesinhibitionofpriondiseaseassociatedneurotoxicitybyanantiprionproteinantibody
AT johncollinge highcontentneuronimagingassaydemonstratesinhibitionofpriondiseaseassociatedneurotoxicitybyanantiprionproteinantibody